Relevance of Old-fashioned Clinical Pharmacology to Modern Anticancer Chemotherapy (NIH-Only)

 


  Launch in standalone player
 
Air date: Tuesday, April 24, 2007, 8:30:00 AM
Category: NCI CCR Grand Rounds (NIH Only)
Runtime: 60 minutes
NLM Title: Relevance of old-fashioned clinical pharmacology to modern anticancer chemotherapy [electronic resource] / Merrill J. Egorin.
Series: CCR grand rounds
Author: Egorin, Merrill J.
Center for Cancer Research (National Cancer Institute (U.S.))
Publisher: [Bethesda, Md. : National Institutes of Health, 2007]
Other Title(s): CCR grand rounds
Abstract: (CIT): Center for Cancer Research - National Cancer Institute Grand Rounds Dr. Egorin received his medical degree and training in internal medicine from the Johns Hopkins University School of Medicine and Hospital. Early in his career, he joined the Baltimore Cancer Research Center, then part of the National Cancer Institute. In 1981, he became a staff physician at the University of Maryland Hospital, where he rose to the position of Professor of Medicine, Pharmacology and Experimental Therapeutics and Oncology. Dr. Egorin was recruited to the University of Pittsburgh Cancer Institute in 1998 to lead its clinical and preclinical pharmacology activities. His research focuses on rational development and application of antineoplastic agents. Key concepts regularly addressed in Dr. Egorin's research involve the pharmacokinetics and pharmacodynamic relationships of investigational and licensed antineoplastic agents and how those relationships can be assessed and modeled. Dr. Egorin's professional affiliations include a fellowship in the American College of Physicians and memberships in the American Association for Cancer Research, the American Society for Clinical Oncology, the American Society for Clinical Pharmacology and Therapeutics and the American Society for Pharmacology and Experimental Therapeutics. He serves on the editorial boards of several medical journals and is editor-in-chief of Cancer Chemotherapy and Pharmacology. Dr. Egorin has authored or co-authored numerous book chapters and more than 250 articles in peer-reviewed journals. The primary educational objective of these seminars is to provide new information, ideas, and discussion about timely areas of research with impact on the field of oncology. A secondary educational objective is to elicit participation by individuals from all divisions of the intramural NCI, and thus facilitate more interactions among investigators and groups in the NCI.
Subjects: Antineoplastic Agents--pharmacology
Neoplasms--drug therapy
Pharmacology, Clinical
Publication Types: Government Publications
Lectures
NLM Classification: QV 269
NLM ID: 101306103
CIT File ID: 13782
CIT Live ID: 5826
Permanent link: http://videocast.nih.gov/launch.asp?13782